Judge Announces Trial Dates for Consolidated NuvaRing DVT Trials
Tampa, FL (Law Firm Newswire) September 27, 2012 – Women who suffered from DVT, blood clots or pulmonary embolism after using the NuvaRing contraceptive device have filed lawsuits against the manufacturer, and a federal judge has announced a trial date for the consolidated cases.
“DVT and pulmonary embolism are quite serious conditions,” said Greg Grambor, an expert on DVT and president of VascularPRN, a distributor of DVT prevention devices. “An important preventative measure is the use of compression therapy, usually when a patient is confined to bed for three days or more.”
Deep Vein Thrombosis, or DVT, is blood clot that occurs in a deep vein, predominantly in the leg. It is characterized by swelling, pain, warmness and redness. Pulmonary embolism is often a result of DVT and occurs when a blood clot comes off and travels to the lung, blocking the main artery or one of its branches. In patients requiring long hospital stays, venous compression devices can prevent the conditions by applying pressure to the legs, thereby increasing blood flow.
NuvaRing is a vaginal ring contraceptive that is used once a month, and releases hormones into the bloodstream. The device is produced by Merck and Organon Pharmaceuticals, and was marketed as having less hormones than other contraceptives.
According to the FDA, the agency has received more than 1,000 reports of injury or death resulting from a blood clot injury in women who used NuvaRing. The FDA released a report last year that said that that type of contraceptive may heighten the risk of blood clots perhaps as much as 56 percent of the time. According to a study from the British Medical Journal, the increased risk may be as much as 90 percent.
A federal judge will hear the consolidated cases in a Missouri Multi-District Litigation court. More than 1,000 patients have filed suits. Judge Rodney W. Sippel said that a trial date in May 2013 has been set for the first of the trials.
To learn more about frequently asked questions regarding DVT, and view the PolyGel portable device, Sequential Compression Devices, or IPC devices, visit http://www.vascularprn.com/or call 800.886.4331. Vascular PRN has decades of experience helping nursing homes, surgery centers and hospitals, managed care organizations, and other institutions with their DVT product needs.
601 S. Falkenburg Road, Suite 1-4
Tampa, FL 33619
View Larger Map
- Public Wants Well-Rested Medical Residents to Ensure Safe Patient Care
A new national poll shows that the vast majority of the American public favors restricting the work shifts of medical residents (also known as resident physicians) to no more than 16 straight hours without sleep, according to a press release from Public Citizen. Importantly, 86% of the public is opposed to lifting the 16-hour cap […]
- Rapid-Inflation Intermittent Pneumatic Compression for Prevention of Deep Venous Thrombosis
Eisele R, Kinzl L, Koelsch T:J Bone Joint Surg Am. 89:1050-6, 2007 Over 1800 consecutive inpatients were enrolled in this randomized prospective clinical study. A total of 902 patients were managed with chemoprophylaxis alone and 901 patients received chemoprophylaxis augmented with [VenaFlow] intermittent pneumatic compression (IPC). All patients were Dopplered for evidence of symptomatic and […]
- Studies have shown that carefully controlled exercise is safe for patients with lymphedema.
INFORMATION FROM THE NATIONAL CANCER INSTITUTE Exercise does not increase the chance that lymphedema will develop in patients who are at risk for lymphedema. In the past, these patients were advised to avoid exercising the affected limb. Studies have now shown that slow, carefully controlled exercise is safe and may even help keep lymphedema from […]